-Reuters
Lexicon Pharmaceuticals Announces Data On Early Clinical Benefit For INPEFA Will Be Among Five Lexicon-Sponsored Presentations At The American Heart Association Scientific Sessions 2023
Cost-effectiveness data and analyses of financial impact among patients hospitalized for heart failure and treated with INPEFA included as important data selected for presentationINPEFA® (sotagliflozin) recently